Newsroom

Press Releases

June 19, 2025

CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells

CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that its ligand conjugated lipid nanoparticle (“LNP”) successfully targeted cancer cells and avoided non-cancerous cells

June 9, 2025

CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform

CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced that it will expand its preclinical program to include liver cancers, specifically rare stem cell-like forms of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Patients with these stem cell-like tumors have a significantly worse survival than patients with more traditional liver tumors

June 5, 2025

CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle

CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform designed to use the body’s immune system to treat cancer, today announced the successful creation of its nanoparticle that can target specific cells that are potentially cancerous

June 3, 2025

CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform

CancerVax, Inc., the developer of a breakthrough universal cancer treatment (UCT) platform that will use the body’s immune system to fight cancer, today announced that two of its lead scientists, Dr. George Katibah and Dr. Adam Grant, were recently featured on Cytiva’s influential podcast series, Discovery Matters. The episode highlights CancerVax’s revolutionary approach to immunotherapy and its mission to create a therapy that can universally target and destroy cancer cells

News Commentary

Thumbnail

- May 12, 2025 - CancerVax News Commentary

Thumbnail

- January 13, 2025 - CancerVax News Commentary

Thumbnail

- January 6, 2025 - CancerVax News Commentary